My Cart

0 Item(s): $0.00

You have no items in your shopping cart.

Apixaban Generic Name

Apixaban Generic Name

Apixaban

Apixaban (Eliquis) is an expensive drug used to lower the chance of stroke in people with a medical condition called atrial fibrillation. It is also used to treat or prevent clots in the lungs or in the veins. This drug is slightly less popular than comparable drugs. There are currently no generic alternatives for Eliquis. It is covered by most Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. The lowest GoodRx price for the most common version of Eliquis is around $424.65, 19% off the average retail price of $526.54. Compare anticoagulants.

What are the uses for apixaban?

Apixaban is used for reducing the risk of blood clots in the heart and strokes in patients with atrial fibrillation who have no problems with their heart valves (nonvalvular atrial fibrillation).

It also is used for treating and preventing deep venous thrombosis (DVT) and pulmonary embolism in patients who have undergone hip or knee replacement surgery.

Indications for ELIQUIS:

To reduce risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF). Prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE) in patients who have undergone hip or knee replacement surgery. Treatment of DVT or PE. To reduce risk of recurrent DVT and PE following initial therapy.

Who is Prescription Hope?

Prescription Hope is a nationally recognized prescription medication access program, headquartered in Columbus, Ohio. We access over 1,500 FDA-approved prescription medications for the set price of $50 per month for each medication. This covers 100% of the medication cost no matter the retail price.

Prescription Hope is NOT a prescription discount card or an insurance plan.

Warnings/Precautions:

Premature discontinuation increases risk of thrombotic events; if discontinued for reason other than bleeding or therapy completion, consider alternative anticoagulant. Risk of spinal/epidural hematoma in anticoagulated patients receiving neuraxial anesthesia or undergoing spinal/epidural puncture (see full labeling); monitor for signs/symptoms of neurological impairment. Increased risk of bleeding; evaluate any signs/symptoms of blood loss; discontinue if active pathological hemorrhage occurs. Patients with prosthetic heart valves, as initial treatment of PE in hemodynamically unstable patients or who require thrombolysis or pulmonary embolectomy: not recommended. Moderate hepatic impairment. Severe hepatic impairment: not recommended. Labor & delivery. Pregnancy (Cat.B). Nursing mothers: not recommended.

Interactions:

See Adult dose. Potentiated by combined P-gp and strong CYP3A4 inhibitors. Antagonized by combined P-gp and strong CYP3A4 inducers (eg, rifampin, carbamazepine, phenyt­oin, St. John’s wort); avoid. Increased risk of bleeding with concomitant aspirin, antiplatelet agents, fibrinolytics, other anticoagulants, heparin, thrombolytic agents, SSRIs, SNRIs, NSAIDs.

Overdose

If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center. Symptoms of overdose may include: bloody/black/tarry stools, pink/dark urine, unusual/prolonged bleeding.

Laboratory and/or medical tests (such as hematocrit/hemoglobin, red blood cell count) may be performed periodically to monitor your progress or check for side effects. Consult your doctor for more details.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip themissed dose and resume your usual dosing schedule. Do not double the dose to catch up.

Storage

Store at room temperature away from light and moisture. Do not store in the bathroom. If you are crushing the tablet and mixing it as directed in water, apple juice, or applesauce, use the mixture within 4 hours of preparing it. Keep all medications away from children and pets.

Conclusion:

This study shows that apixaban is superior to warfarin in preventing strokeand systemic embolism in patients with non-valvular atrial fibrillation or flutter and atleast one additional risk factor for stroke. This study also showed that apixaban resultedin both a statistically and clinically significant lower rate of major and clinically relevantnonmajor bleeding events compared to warfarin. Further studies are needed to determine.

Know More About This Medicine and Buy Now :  MedyPharma.com

Loading...